Get an alert when PIERRE FABRE LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-01-11 (in 8mo)

Last made up 2025-12-28

Watchouts

None on the register

Cash

£1M

-0.3% vs 2023

Net assets

£2M

+18.8% vs 2023

Employees

80

-2.4% vs 2023

Profit before tax

£2M

+25.8% vs 2023

Name history

Renamed 1 time since incorporation

  1. PIERRE FABRE LIMITED 1987-09-25 → present
  2. CONCEPT PHARMACEUTICALS LIMITED 1970-08-12 → 1987-09-25

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £36,775,120£42,995,183
Operating profit £1,293,900£1,499,420
Profit before tax £1,276,516£1,606,425
Net profit £999,488£1,175,873
Cash £1,501,888£1,497,665
Total assets less current liabilities £1,829,720£2,174,593
Net assets £1,829,720£2,174,593
Equity £1,829,720£2,174,593
Average employees 8280
Wages £6,123,224£6,182,564

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 3.5%3.5%
Net margin 2.7%2.7%
Return on capital employed 70.7%69.0%
Gearing (liabilities / total assets) 87.4%92.7%
Current ratio 1.12x1.07x
Interest cover 74.43x92.34x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Forvis Mazars LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors have made an assessment in preparing the financial statements as to whether the Company is a going concern. After reviewing the Company's forecasts and projections, including cash flow forecasts, as well as transfer pricing to ensure a fixed profit margin, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company has also received a group letter of support from its ultimate parent company and therefore adopts the going concern basis in preparing its financial statements.”

Group structure

  1. PIERRE FABRE LIMITED · parent
    1. Concept Pharmaceuticals (International) Limited 100% · United Kingdom · Dormant

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

5 active · 17 resigned

Name Role Appointed Born Nationality
DEMIRDERE, Hande Director 2023-05-01 Oct 1973 Turkish
GIL, Sylvie Marina Director 2019-05-20 Dec 1965 French
MAGALLON, Sophie Suzanne Augusta Director 2019-05-20 Oct 1971 French
PEYON, Alan Hervé Director 2025-02-10 Sep 1975 French
RUER, Renaud-Thomas Director 2025-04-01 Sep 1980 French
Show 17 resigned officers
Name Role Appointed Resigned
GRAYS INN SECRETARIES LIMITED Corporate Secretary 1992-12-28 2019-02-28
BENOIST, Xavier Pierre Marie Director 2014-03-27 2025-03-31
BODSON, Marc Director 1998-07-25 2000-04-30
DANON, Michael Frédéric Director 2014-03-27 2019-05-20
DARBEAU, Daniel Director 1996-10-18 1998-12-15
DELABARRE, Fabrice Director 2020-07-17 2024-03-25
DUCHESNE, Frédéric Marie Director 2014-03-27 2019-04-08
FABRE, Jacques Director 1996-10-18
FABRE, Pierre Director 1998-07-25
GORDON, George Charles Director 1993-01-31
GRANGE, Martin Andrew Director 1997-02-20 2014-03-27
GUIRAUD-CHAUMEIL, Vincent Henri Francois Director 2017-11-10 2020-07-17
GUIRAUD-CHAUMEIL, Vincent Henri Francois Director 2014-03-27 2014-06-24
HEATHER, Karen Jane Director 2014-03-27 2018-09-07
HURTELOUP, Patrick Director 2000-04-30 2014-03-27
MCMULLIN, Laura Adele Director 2018-04-09 2023-02-28
NAAL, Santoke Singh Director 2014-06-24 2017-11-10

Ownership

Persons with significant control

No persons with significant control on record.

Filing timeline

Last 20 of 156 total filings

Date Type Category Description
2026-01-09 CH01 officers Change person director company with change date PDF
2026-01-09 CH01 officers Change person director company with change date PDF
2026-01-09 CH01 officers Change person director company with change date PDF
2026-01-09 CH01 officers Change person director company with change date PDF
2026-01-08 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-04-02 AP01 officers Appoint person director company with name date PDF
2025-03-31 TM01 officers Termination director company with name termination date PDF
2025-03-21 AA accounts Accounts with accounts type full
2025-02-11 AP01 officers Appoint person director company with name date PDF
2025-01-02 CH01 officers Change person director company with change date PDF
2024-12-30 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-05-14 AA accounts Accounts with accounts type full
2024-03-27 TM01 officers Termination director company with name termination date PDF
2024-01-05 CH01 officers Change person director company with change date PDF
2024-01-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-01-02 CH01 officers Change person director company with change date PDF
2023-05-11 AP01 officers Appoint person director company with name date PDF
2023-04-06 AD01 address Change registered office address company with date old address new address PDF
2023-03-14 AA accounts Accounts with accounts type full
2023-03-02 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
5

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page